SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
14998844
Source:
http://linkedlifedata.com/resource/pubmed/id/14998844
Search
Subject
(
61
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0034541
,
umls-concept:C0079083
,
umls-concept:C0282461
,
umls-concept:C0684249
,
umls-concept:C1517927
,
umls-concept:C1519810
pubmed:issue
3
pubmed:dateCreated
2004-3-4
pubmed:abstractText
To determine the radiosensitizing effect of prolonged exposure of carboplatin in patients with locally unresectable non-small-cell lung cancer (NSCLC).
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/14998844-15386828
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9007735
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin
,
http://linkedlifedata.com/resource/pubmed/chemical/Radiation-Sensitizing Agents
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0923-7534
pubmed:author
pubmed-author:FokkemaEE
,
pubmed-author:GroenH J MHJ
,
pubmed-author:HermannMM
,
pubmed-author:HoekstraH JHJ
,
pubmed-author:MulderN HNH
,
pubmed-author:NabersJJ
,
pubmed-author:NossentG DGD
,
pubmed-author:OtterRR
,
pubmed-author:SmitW J G MWJ
,
pubmed-author:TimmerP RPR
,
pubmed-author:de VriesE G EEG
,
pubmed-author:van PuttenJ W GJW
,
pubmed-author:van der LeestA H WAH
pubmed:issnType
Print
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
427-32
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:14998844-Carcinoma, Non-Small-Cell Lung
,
pubmed-meshheading:14998844-Cisplatin
,
pubmed-meshheading:14998844-Combined Modality Therapy
,
pubmed-meshheading:14998844-Disease-Free Survival
,
pubmed-meshheading:14998844-Female
,
pubmed-meshheading:14998844-Follow-Up Studies
,
pubmed-meshheading:14998844-Humans
,
pubmed-meshheading:14998844-Infusions, Intravenous
,
pubmed-meshheading:14998844-Lung Neoplasms
,
pubmed-meshheading:14998844-Male
,
pubmed-meshheading:14998844-Middle Aged
,
pubmed-meshheading:14998844-Quality of Life
,
pubmed-meshheading:14998844-Radiation-Sensitizing Agents
,
pubmed-meshheading:14998844-Survival Rate
pubmed:year
2004
pubmed:articleTitle
Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study.
pubmed:affiliation
Department of Pulmonary Diseases, University Hospital Groningen, The Netherlands. h.j.m.groen@int.azg.nl
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study
,
Clinical Trial, Phase III